Analyst firms · H.C. Wainwright · BDSI

H.C. Wainwright BDSI price target and rating history

BioDelivery Sciences International Inc. (BDSI) · Health Care

H.C. Wainwright rates BioDelivery Sciences International Inc. (BDSI) Neutral with a $4.50 price target, as of its latest action on Jan 21, 2022. It has published 3 rating actions on BDSI since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$4.50
Median target, all firms
Too few
Actions on BDSI
3

H.C. Wainwright price target on BDSI

$6$5.25$4.5020222023202420252026
H.C. Wainwright price target on BDSI, each point a stated target, August 2021 to January 2022.

Every H.C. Wainwright rating on BDSI

Questions about H.C. Wainwright and BDSI

What is H.C. Wainwright's price target for BDSI?
H.C. Wainwright's latest stated price target for BioDelivery Sciences International Inc. (BDSI) is $4.50, from its action on Jan 21, 2022.
What is H.C. Wainwright's rating on BDSI?
H.C. Wainwright rates BDSI Neutral, a neutral rating, as of Jan 21, 2022.
When did H.C. Wainwright last change its view on BDSI?
On Jan 21, 2022, H.C. Wainwright raises its price target to $4.50 from $4, keeps Neutral.

All H.C. Wainwright ratingsBDSI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.